Kangmei Pharma reported CNY1.67M in Interest Expense on Debt for its fiscal quarter ending in March of 2025.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.35M 230K Jun/2024
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Genomma Lab Internacional MXN 194.27M 25.83M Jun/2025
Hypermarcas BRL 253.18M 210.09M Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Jiangsu Hengrui CNY 2.25M 2.25M Dec/2024
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Moderna USD 1000K 0 Jun/2025
Organon & Co USD 131M 7M Jun/2025
Revvity USD 22.94M 27K Jun/2025
Sh Fosun Pharma CNY 329.53M 28.8M Mar/2025
Tectonic Therapeutic USD 17K 5K Jun/2025
Viatris USD 116.6M 1.1M Jun/2025
Wuxi Apptec CNY 103.05M 37.29M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025